oramed.com (ORMP) - Cash on Hand per Share

Oramed Pharmaceuticals Inc. - graphic logo of issuer ORMP

Oramed Pharmaceuticals' unstable cash flow is driven by a shift toward an investment strategy following the failure of its primary project. Analyzing the cash per share on GURU.Markets, we note that the value 1.24 describes the current liquidity level. Meanwhile, strict warehouse control of insulin products guarantees distribution quality, and the diversification of raw material supply chains for capsules eliminates logistical disruptions.

oramed.com - ORMP Cash per Single Share (period 07/04/2022 - 11/20/2026)

Comprehensive metric breakdowns and analytics for oramed.com (ORMP)

- market capitalization indicators:
- cash availability and cash flow indicators:
Summary company analysis:ORMP, Oramed
Manufactured products of Oramed Pharmaceuticals

This metric determines the share of liquid assets per common share, measuring the actual cash backing of the capital. Investors use this metric to assess the intrinsic value of the company and analyze the margin of safety in the absence of revenue. By analyzing fluctuations in cash per share, one can track the burn rate of resources allocated to operating activities. For Oramed Pharmaceuticals (ORMP), this is critical when implementing patent protection strategies and establishing joint ventures. Optimizing the cash cushion allows the issuer to effectively manage intellectual property in the field of oral drug delivery.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)